Presentation ITALIC: 6- vs 24-Month DAPT After Implantation of DES in Patients Nonresistant to Aspirin Presenter: Martine Gilard March 10, 2015
News Daily News ITALIC Published: No Benefit to Long-Term DAPT After Stenting Yael L. Maxwell March 10, 2015
News Industry News New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions February 24, 2015
News Opinion Fellow Talk Fellow Talk: Conferences Galore: Why You Should Go, Which One(s) to Choose Siddharth A. Wayangankar, MD, MPH February 23, 2015
News Daily News Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM L.A. McKeown February 22, 2015
News Daily News Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI L.A. McKeown February 22, 2015
Presentation CADECI 2015 Uso responsable de Rivaroxabán en prevención secundaria después de un SCA:Casos clínicos_ Presenter: DR. JOSE LUIS LEIVA PONS February 20, 2015
News Daily News Un Amplio Estudio de Registro Sugiere que el Enchufe Amplatzer Reduce los Riesgos Hemorrágico y de ACV en el Manejo de la FA Todd Neale February 17, 2015
News Daily News Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib Todd Neale February 17, 2015
News Daily News German Database: Poor Prognosis of Critical Limb Ischemia Patients Linked in Part to Undertreatment February 10, 2015
Presentation LAA Occlusion for Stroke Prevention in A-Fib Presenter: Apostolos Tzikas January 29, 2015
News Daily News La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban Todd Neale January 28, 2015
News Daily News High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits January 28, 2015
News Daily News HF Worsens Outcomes Following ACS, With No Benefit From Apixaban Todd Neale January 28, 2015